SEC Form 4 · accession 0001209191-15-079529
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David W. Oldach
Officer — Chief Medical Officer
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 9:19 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2015 | M | 10,000 | $2.28 | A | 13,300 | D | |
| Common StockF1 | Nov 9, 2015 | S | 10,000 | $28.78 | D | 3,300 | D | |
| Common StockF2 | Nov 9, 2015 | S | 2,200 | $28.78 | D | 1,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F8 | $2.28 | Nov 9, 2015 | M | 10,000 | A | — | Feb 28, 2021 | Common Stock | 10,000 | 26,347 | D |
| Employee Stock Option (Right to Buy)F3 | $23.51 | holding | — | — | — | — | Dec 31, 2024 | Common Stock | 23,000 | 23,000 | D |
| Employee Stock Option (Right to Buy)F4 | $13.10 | holding | — | — | — | — | Jan 7, 2024 | Common Stock | 7,500 | 7,500 | D |
| Employee Stock Option (Right to Buy)F5 | $6.64 | holding | — | — | — | — | Mar 6, 2023 | Common Stock | 10,000 | 10,000 | D |
| Employee Stock Option (Right to Buy)F6 | $6.63 | holding | — | — | — | — | Jan 17, 2023 | Common Stock | 14,087 | 14,087 | D |
| Employee Stock Option (Right to Buy)F7 | $7.47 | holding | — | — | — | — | Mar 20, 2022 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.70 to $28.84, inclusive.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.7801 to $28.82, inclusive.
- F3The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2015.
- F4The option vests according to the following schedule: 1/48th of the shares vest at the end of each month over 48 months, beginning after 01/01/2014.
- F5The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- F6The option vested according to the following schedule: 1/4th of the shares vest at the end of each quarter, beginning after 01/01/2013.
- F7The option vested on the one-year anniversary of the 03/21/2012 grant date.
- F8The option vests according to the following schedule: 1/4th of the shares vest on the one-year anniversary of the 03/01/2011 grant date; 1/36th of the remaining shares vest at the end of each month over the next 36 months.